The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
THE SO WHAT
For oncology operators, the question isn’t just whether Moderna’s cancer vaccine can match Keytruda in the short term—it’s whether it can durably suppress recurrence over years, which changes trial design, follow-up infrastructure, and payer negotiations. Early data will drive headlines, but long-term outcomes will drive formulary and care-pathway rewrites.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging TechAI Ushers in New Era of Cybersecurity Needs
The White House treating PHP flaws as a national infrastructure risk is a reminder that AI-era security failures will often start in old code, not new models. If your stack still leans on legacy languages and libraries, your AI roadmap is only as credible as your software supply-chain hygiene.
Deep & Emerging TechNATO jammers will block out GPS for miles around — and they could be the secret weapon in the next big conflict
NATO training with large-scale GPS jamming is a blunt reminder that positioning and timing are wartime targets, not utilities. Any autonomy, logistics, or telecom system that quietly assumes GPS reliability needs a resilience review now, not after a disruption.
Deep & Emerging TechXona Raises $250 Million to Remake 50-Year-Old GPS
A $250M round at a $2.45B valuation to rebuild GPS with a commercial satellite network shows navigation is being treated as strategic infrastructure, not a free public good. Any product that depends on precise, reliable positioning—AVs, drones, logistics—should be tracking alternative PNT providers as potential resilience and performance levers.
Deep & Emerging TechAI chipmaker Cambricon’s sales miss points to tight chip supply in China
Cambricon doubling revenue to 3.53B yuan yet missing a 6.26B forecast underscores that China’s AI chip growth is now gated by HBM and advanced fab access, not demand. If you operate in or sell into China, plan for persistent supply volatility and consider architectures that can flex across multiple accelerator vendors.